

FRIDAY, 9:30 - 10:30
Olga Potapova, PhD, Cureline, Inc (CEO & Scientific Director) & Irina Zaytseva, MBA, Cureline, Inc (VP Business Development)
Workshop Overview
Standard methods for preservation of tissue specimens for molecular analyses, including freezing and embedding in paraffin, have not undergone significant improvements for many years, are not energy efficient, and require long-term investments in complex and expensive infrastructure. Cureline is an experienced player in the international biobanking arena, and we collaborate with various institutions on development of tissue procurement technologies that may improve commercialization of human biospecimens. An overview of existing cutting age methods and new trends for tissue preservation will be given. A special emphasis will be on methods developed recently for preservation of solid tissue specimens. An access to these powerful technologies can bring any biobanking organization to a new level of servicing academic investigators and biopharmaceutical industry. The presentation will be supported with real examples/speakers and discussion of new trends in tissue preservation and commercialization.
Workshop Facilitators: Olga Potapova, PhD, Irina Zaytseva, MBA
Dr. Potapova and Ms. Zaytseva from Cureline, Inc. a global biospecimen management company that collaborates with major clinical and research centers in Europe, Asia, and the USA on human tissue acquisition projects. Cureline has a Tissue Biorepository which contains more than 5,000 annotated clinical cases (about 70,000 fully-annotated biospecimens).
Who Should Attend?
Scientists working with human tissues, and biobanking managers determining the tissue procurement procedures.
How you will benefit from this Workshop:
• You will learn what the most advanced tissue procurement methods and technologies are in the biobanking science.
• You will learn how the presented technologies can improve the commercialization of human biospecimens.
• You will be able to interact with leading specialists on the subject.
• You will be able to participate in an open discussion with end users of presented technologies and learn from their experience.